Tag Archive for Dag Bergheim Pettersen

Hot Business News Today

Zinzino Preliminary Sales Report February 2026

by  •  • 0 Comments

Zinzino group revenue increased with a total of 32 %, compared with the previous year.
The revenue in February for Zinzino‘s sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma’s external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year.
Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.
Revenues were distributed as follows:

Regions, MSEK
26-Feb
25-Feb
Change
YTD 2026
YTD 2025
Change

The Nordics
22.5
24.8
-9%
50.1
50.5
-1%

Central Europe
81.8
57.4
43%
171.0
126.8
35%

East Europe
26.2
29.0
-10%
55.9
63.2
-12%

South & West Europe
50.2
37.8
33%
97.2
82.0
19%

The Baltics
8.5
8.8
-3%
18.9
19.3
-2%

North America
67.5
32.5
108%
109.9
53.8
104%

South America
3.6
1.2
200%
7.5
2.1
257%

Asia-Pacific
18.6
19.7
-6%
41.7
41.2
1%

Africa
2.2
1.5
47%
4.1
3.0
37%

Zinzino
281.1
212.7
32%
556.3
441.9
26%

Faun Pharma
5.2
4.2
24%
12.3
8.9
38%

Zinzino Group
286.3
216.9
32%
568.6
450.8
26%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven

Read more...

Hot Business News Today

Zinzino Publishes 2025 Year-End Report: 51% Growth

by  •  • 0 Comments

Increases Dividend By 50% To SEK 6 After High Growth And Significant Improvement In Profitability. 
Zinzino AB (publ) (ZZ-B.ST), a global direct-sales company, reports that revenue for the fourth quarter of 2025 amounted to SEK 1,035.3 (713.5) million, corresponding to 45% (35%) growth compared with the same period last year. In local currencies, revenue for the fourth quarter increased by 52% compared with the corresponding period last year. EBITDA rose to SEK 175.2 (72.9) million after the EBITDA margin increased to 16.9% (10.2%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino acquired 35% of the shares in Xion International Group with the aim of producing algae using bioreactors, thereby securing a sustainable future supply of omega-3 for the company’s main product, BalanceOil. In addition, the assets of the direct sales company Sanki were acquired to increase distribution power in North and South America, and the Gut Health Test was launched.
For the full year 2025, total revenue amounted to SEK 3,337.5 (2,207.8) million, corresponding to 51% (25%) growth compared with the previous year. EBITDA amounted to SEK 443.4 (250.7) million

Read more...

Hot Business News Today

Zinzino Announces Merger of It Works! For Increased Distribution Power in North America and Europe

by  •  • 0 Comments

Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
Zinzino (publ) (ZZ-B.ST) has today entered into an agreement, and simultaneously closed, to combine with the US-based direct sales company It Works! In an all-share transaction. Through the merger, Zinzino acquired the operational assets of It Works!’ US business, including inventory, distributor agreements, customer agreements, and IP rights, as well as 100% of the shares in It Works! Marketing International UC, an Irish unlimited company, and its wholly owned subsidiaries.
The fixed purchase price amounts to USD 30 million (the “Purchase Price”) which has been paid by Zinzino through a directed set-off issue of 1,843,840 B-shares in Zinzino (the “Directed Issue”). The Directed Issue has been resolved upon by the board of directors of Zinzino, based on the authorization of the Annual General Meeting. The subscription price in the Directed Issue amounts to SEK 145.62 per B-share, which corresponds to the volume weighted average price of Zinzino’s B-share two business days prior to the signing and closing of the transaction. In addition, an additional purchase price estimated to USD 4 million could be paid to It Works! during a five-year span

Read more...

Hot Business News Today

Zinzino Sales Growth November 2025

by  •  • 0 Comments

Zinzino AB (PUBL.): Preliminary Sales Report November 2025

Zinzino group revenue increased with a total of 45 %, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma’s external sales decreased and amounted to SEK 4.3 (10.1) million.
Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.
Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.
Revenues were distributed as follows:

Regions, MSEK
25-Nov
24-Nov
Change
YTD 2025
YTD 2024
Change

The Nordics
29.7
29.0
2%
301.0
272.3
11%

Central Europe
133.9
70.4
90%
892.2
518.7
72%

East Europe
51.5
51.6
0%
361.9
366.0
-1%

South & West Europe
58.7
45.3
30%
513.9
346.7
48%

The Baltics
17.3
16.1
7%
115.4
95.6
21%

North America
58.1
25.8
125%
491.0
179.2
174%

Asia-Pacific
23.0
11.1
107%
263.7
64.4
309%

Africa
2.8
2.5
12%
21.1
15.1
40%

Zinzino
375.0
251.8
49%
2960.2
1858.0
59%

Faun Pharma
4.3
10.1
-57%
47.3
97.1
-51%

Zinzino Group
379.3
261.9
45%
3007.5
1955.1
54%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

View as PDF
SOURCE: Zinzino
About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier

Read more...

Hot Business News Today

Zinzino Interim Report For Q3 2025

by  •  • 0 Comments

Strong sales growth and increased profit margins drive profitability upwards
To view the full report, go to: Zinzino Interim Report Q3 2025
Revenue for the third quarter of 2025 amounted to SEK 784.1 (532.8) million, corresponding to 47% (22%) growth compared with the same period last year. In local currencies, revenue for the third quarter increased by 53% compared with the corresponding period last year.
EBITDA increased to SEK 109.7 (63.0) million after the EBITDA margin increased to 14.0% (11.8%).
The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino also acquired the assets of the US-based direct sales companies Bodē Pro and Truvy to increase distribution power in North America, Latin America, South Korea and Japan.
JULY-SEPTEMBER 2025

Total revenue amounted to SEK 784.1 (532.8) million, corresponding to a growth of 47% (22%)
Gross profit amounted to SEK 277.2 (178.8) million and the gross profit margin was 35.4% (33.6%)
EBITDA amounted to SEK 109.7 (63.0) million and the EBITDA margin was 14.0% (11.8%)
Net profit amounted to SEK 89.4 (42.6) million
Net profit per share after tax before dilution amounted to SEK 2.47 (1.24)
Cash flow from operating activities

Read more...

Hot Business News Today

Zinzino Preliminary Sales Report: October Shows 65% Increase

by  •  • 0 Comments

Zinzino Preliminary Sales Report October 2025: Revenue increased a total of 65 %, as compared with the previous year.
The revenue in October for Zinzino‘s sales markets increased by 70 % and amounted to SEK 324.8 (191.6) million. Faun Pharma’s external sales decreased and amounted to SEK 2.7 (7.3) million.
Overall, the Group increased revenues by 65 % to SEK 327.5 (198.9) million compared with the previous year.
Accumulated revenue for January – October 2025 increased by 55 % to SEK 2,629.7 (1,693.2) million.
Revenues were distributed as follows:

Regions, MSEK
25-Oct
24-Oct
Change
YTD 2025
YTD 2024
Change

The Nordics
36.3
29.3
24%
270.3
243.3
11%

Central Europe
101.3
53.9
88%
758.9
448.3
69%

East Europe
34.4
34.5
0%
310.3
314.4
-1%

South & West Europe
57.8
37.0
56%
455.8
301.5
51%

The Baltics
13.0
10.1
29%
98.2
79.5
24%

North America
51.6
19.3
167%
433.6
153.3
183%

Asia-Pacific
28.1
5.8
384%
241.3
53.3
353%

Africa
2.3
1.7
35%
18.3
12.6
45%

Zinzino
324.8
191.6
70%
2586.7
1606.2
61%

Faun Pharma
2.7
7.3
-63%
43.0
87.0
-51%

Zinzino Group
327.5
198.9
65%
2629.7
1693.2
55%

Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
– Africa: South Africa
SOURCE: Zinzino
About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on

Read more...

Hot Business News Today

Zinzino Celebrates 20 Years of Growth and Global Impact at Vision 2025

by  •  • 0 Comments

Zinzino, the fast-growing Scandinavian-based global wellness and test-based nutrition company, celebrated its 20-year anniversary with a spectacular Vision 2025 Annual Event in Oslo, Norway, earlier this month.
Nearly 5,000 Zinzino Partners and guests filled The Qube arena in Oslo, Norway, October 9 – 12, with thousands more joining virtually from around the world — all united by one mission:
to bring the world back in balance.
The event marked two decades of passion, innovation, and people empowering people — a milestone celebration that combined inspiration, recognition, and scientific breakthrough moments that will define the company’s next era.
Watch Zinzino’s recap video below:

Four Days of Leadership, Learning & Celebration
The convention opened Thursday with Annual Leadership Day for qualifying Diamonds and above.

Co-founder and 5-Star Global President Ørjan Sæle and CEO Dag Bergheim Pettersen shared visionary messages on leadership and growth, followed by keynote trainings from Terri Brady, Chris Brady, Laurie Woodward, and Orrin Woodward.

Friday and Saturday featured main-stage sessions on new product innovations and a Science Panel with Dr. Colin Robertson, Dr. Martina Torrissen, and Dr. Paul Clayton.

Corporate leaders presented new business tools while recognizing top field achievements across all ranks.

New Product Breakthrough
Zinzino’s new product breakthrough sets the stage for the next generation of gut health

Read more...

Hot Business News Today

Zinzino Pioneering Gut Health Testing With a Simple Finger Prick

by  •  • 0 Comments

Zinzino, the Scandinavian health and wellness company, today announced the launch of its innovative Gut Health Test. With a simple at-home finger prick, this is the first commercial test to measure what gut bacteria produce and how the body responds, providing fresh insights into how diet and lifestyle affect immune defense and overall health. By eliminating the need for stool samples, the test makes preventative gut health routines and personalized diets easier and more accessible.
Research indicates that a balanced gut supports the whole body.  More than 70% of the body’s immune system is in the gut, and every gut microbiome is different.¹ Traditional microbiome (stool) tests only look at the diversity of microbes present in the gut.
Zinzino’s Gut Health Test is the first of a new generation of gut health tests that measure gut function and whether these processes strengthen or strain the immune system.² Individuals can then use the test results to take proactive steps to restore their unique gut-metabolic balance with diet and lifestyle adjustments. The test is available now for purchase online or through selected distributors.

“This is the future of gut health testing,”

says Colin Robertson, Chief Product Officer at Zinzino.

“The gut is the center of the human universe, driving overall health and

Read more...

Hot Business News Today

Zinzino Preliminary Sales Report: 48% Increase in Q3

by  •  • 0 Comments

Zinzino group revenue increased 48% in Q3, compared with the previous year.
The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.
Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.
Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.
Revenues were distributed as follows:

Regions, mSEK
25-Sep
24-Sep
Change
Q3 2025
Q3 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
26.5
25.4
4%
79.6
72.5
10%
235.1
214.0
10%

Central Europe
93.8
48.7
93%
242.8
138.6
75%
657.9
394.4
67%

East Europe
29.4
28.3
4%
89.7
88.3
2%
276.2
279.9
-1%

South & West Europe
50.1
38.0
32%
137.2
104.2
32%
399.2
264.5
51%

The Baltics
8.9
7.2
24%
28.6
21.9
31%
85.3
69.4
23%

North America
41.3
20.3
103%
129.8
52.6
147%
382.1
134.0
185%

Asia-Pacific
21.6
9.6
125%
63.7
22.3
186%
212.7
47.5
348%

Africa
1.9
1.2
58%
5.8
4.0
46%
16.0
10.9
47%

Zinzino
273.5
178.7
53%
777.3
504.4
54%
2264.5
1414.6
60%

Faun Pharma
3.7
5.8
-36%
9.4
28.4
-67%
40.4
79.7
-49%

Zinzino Group
277.2
184.5
50%
786.7
532.8
48%
2304.9
1494.3
54%

Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong

Read more...

Hot Business News Today

Zinzino Completes Acquisition of Truvy, Increasing North America, Latin America, South Korea Distribution

by  •  • 0 Comments

Zinzino (Zinzino AB) announced its letter of intent earlier this month to acquire the North American direct sales company Truvy. Zinzino has now completed the acquisition process and thereby acquired the rights to Truvy’s distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Truvy’s South Korean subsidiary have been acquired to accelerate the establishment process and increase distribution power in the country.
This is another strategically important step in Zinzino’s growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.
Truvy is a global direct sales company in the health segment, operating in North America, Latin America, and South Korea. Its brand portfolio offers a range of innovative products in the areas of health and weight loss.
The business has a total annual turnover of approximately USD 12 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with Zinzino’s test-based product concept. Profitability through the transactions will thus be able to develop well by utilizing Zinzino’s existing technical platform and organization.
Upon completion, Zinzino will pay a fixed purchase

Read more...